GW-501516
$49.99
GW-501516 is a PPARδ (Peroxisome Proliferator-Activated Receptor Delta) agonist studied for its role in regulating lipid metabolism, endurance capacity, and glucose homeostasis. In vitro, GW-501516 is used to investigate energy expenditure, mitochondrial biogenesis, and fatty acid oxidation pathways.
Description
GW-501516 is a synthetic research compound classified as a PPARδ agonist, with PPARδ standing for peroxisome proliferator-activated receptor delta. PPARδ is a nuclear receptor involved in regulating gene expression related to lipid metabolism, fatty acid oxidation, glucose utilization, and cellular energy balance. Because of this receptor activity, GW-501516 is frequently studied in laboratory environments for its role in metabolic signaling, mitochondrial function, and pathways associated with energy expenditure.
In controlled research settings, GW-501516 is commonly used to investigate how PPARδ activation may influence the way cells process and utilize fatty acids as an energy source. Researchers often examine its effects on lipid transport, oxidative metabolism, and gene networks involved in metabolic adaptation. These studies make GW-501516 a useful reference compound in research focused on fat metabolism, cellular fuel selection, and energy-regulating molecular pathways.
GW-501516 is also studied in relation to mitochondrial biogenesis and endurance-associated signaling. Mitochondrial biogenesis refers to the process by which cells increase mitochondrial content, which can support greater energy production and improved metabolic efficiency in experimental models. In vitro studies may evaluate how GW-501516 influences mitochondrial activity, oxidative capacity, and cellular responses to increased energy demand.
Another major area of research interest involves glucose homeostasis and metabolic flexibility. Researchers may use GW-501516 to study glucose uptake, insulin-associated signaling, and the balance between carbohydrate and lipid metabolism under controlled experimental conditions. These investigations help provide insight into how PPARδ-mediated pathways contribute to broader metabolic regulation and cellular adaptation.
Due to its defined mechanism as a PPARδ agonist, GW-501516 remains an important reference compound in studies involving nuclear receptor activation, lipid metabolism, fatty acid oxidation, mitochondrial signaling, glucose regulation, and experimental models of endurance-related metabolic pathways. Its use in laboratory research supports a better understanding of how receptor-mediated gene regulation can influence cellular energy balance and metabolic function.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.




Reviews
There are no reviews yet.